Loading insider details...
Beta
Latest Form 4 (Jun 18, 2026): Grant/Award of 57,100 ZNTL shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Grant/Award | 57,100 | n/a |
| Feb 10, 2026 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Tender of Shares | 3,800 | n/a |
| Aug 25, 2025 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Purchase | 3,800 | $41.1K |
| Jun 18, 2025 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Grant/Award | 57,603 | n/a |
| Jun 13, 2025 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Grant/Award | 5,758 | n/a |
| Apr 30, 2025 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Purchase | 21,000 | $29.4K |
| Nov 13, 2024 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Grant/Award | 260,192 | n/a |
| May 29, 2024 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Grant/Award | 5,357 | n/a |
| Mar 11, 2024 | Harpoon Therapeutics, Inc. (HARP) | Disposition to Issuer | 22,665 | n/a |
| Jan 3, 2024 | Harpoon Therapeutics, Inc. (HARP) | Grant/Award | 2,048 | n/a |